TD Private Client Wealth LLC Acquires 1,007 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

TD Private Client Wealth LLC increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 21.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,723 shares of the company’s stock after buying an additional 1,007 shares during the period. TD Private Client Wealth LLC’s holdings in Option Care Health were worth $179,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Teachers Retirement System of The State of Kentucky boosted its holdings in Option Care Health by 4.1% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 390,921 shares of the company’s stock worth $12,236,000 after buying an additional 15,357 shares during the period. Barclays PLC boosted its holdings in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after buying an additional 199,454 shares during the period. Pier Capital LLC boosted its holdings in Option Care Health by 88.4% in the 3rd quarter. Pier Capital LLC now owns 231,884 shares of the company’s stock worth $7,258,000 after buying an additional 108,783 shares during the period. Orion Portfolio Solutions LLC boosted its holdings in Option Care Health by 2.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company’s stock worth $884,000 after buying an additional 636 shares during the period. Finally, Zacks Investment Management boosted its holdings in Option Care Health by 7.4% in the 3rd quarter. Zacks Investment Management now owns 60,578 shares of the company’s stock worth $1,896,000 after buying an additional 4,168 shares during the period. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Option Care Health stock opened at $23.49 on Monday. The firm’s fifty day moving average price is $25.40 and its 200-day moving average price is $28.46. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market cap of $4.00 billion, a P/E ratio of 19.74, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on OPCH shares. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Barrington Research lowered their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. UBS Group started coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Finally, Truist Financial lowered their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health currently has an average rating of “Hold” and an average price target of $30.14.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.